Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 49   

Articles published

SKBI 4.21 +0.04 (0.96%)
price chart
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
NEW YORK ( TheStreet) -- Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI) has been upgraded by TheStreet Ratings from sell to hold.
Related articles »  
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 4.13 +0.04 1.08% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Insider Buying: John M. Gregory Buys 38730 Shares of Skystar Bio ...  sleekmoney
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Update: Skystar Bio-Pharmaceutical Company Q3 Earnings - Key Developments ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) reported double-digit increases for both revenue and net income for Q3. Revenue increased 14.8% to $18.4 million, while net income increased 32% to $4.9 million or $0.57 per fully diluted share.
Related articles »  
Update: Skystar Bio-Pharmaceutical Company Insider Trading Disclosure
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the 10% Owner of Skystar Bio-Pharmaceutical Co, Gregory John M, had purchased 38,730 shares ...
Insider Buying: Skystar Bio-Pharmaceutical Company major shareholder ...  Intercooler
Stocks Underperform for the Week: Premier Exhibitions Inc , Skystar Bio ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has lost 4.67% during the past week and dropped 3.6% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 6.17%.
Skystar Bio-Pharmaceutical Company major shareholder Purchases ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory acquired 38,730 shares of the stock in a transaction dated Monday, February 2nd.
Investor Alert on Insider Trading: Skystar Bio-Pharmaceutical Company ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the 10% Owner of Skystar Bio-Pharmaceutical Co, Gregory John M, had purchased 70,800 shares ...
Related articles »  
Skystar Bio-Pharmaceutical Company major shareholder Purchases $469753 in ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 103,016 shares of Skystar Bio-Pharmaceutical Company stock on the open market in a transaction dated ...
Related articles »  
Insider Buying: John M. Gregory Buys 70800 Shares of Skystar Bio ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 70,800 shares of the stock in a transaction that occurred on Tuesday, December 23rd.
John M. Gregory Purchases 70800 Shares of Skystar Bio-Pharmaceutical ...  Intercooler
Related articles »